Delray Beach, FL, July 03, 2025 (GLOBE NEWSWIRE) — What’s powering a $33.8 billion opportunity?
The robotic surgery market is on a fast lane, expected to surge from USD 16.0 billion in 2024 to USD 33.8 billion by 2029, at a robust CAGR of 16.1%. This exponential growth isn’t accidental—it’s fueled by deep technological advancements, rising healthcare automation, and a global urgency to reduce clinical errors and improve outcomes. For C-level leaders, the message is clear: robotics in healthcare isn’t a trend. It’s a long-term transformation strategy.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2916860
Why is robotic surgery becoming the new clinical benchmark?
In operating rooms around the world, robotic surgery is redefining surgical precision and patient recovery. The rise of surgical robots—particularly in soft tissue procedures—is meeting the escalating demand for minimally invasive, data-guided interventions. These robots enable unparalleled accuracy, faster patient turnaround, and a dramatic reduction in complications. For providers, this means greater throughput and for payors, lower long-term costs.
What does a robotic surgery machine solve?
Beyond the operating table, robotic surgery machines solve a multi-billion-dollar problem: medication errors and procedural inefficiencies. From automated dispensing systems in pharmacies to diagnostic and telepresence robots in hospitals, the integration of robotics is minimizing human error, optimizing resource allocation, and enhancing care coordination. It’s not just about surgery—it’s a 360° transformation of care delivery.
Where are the most investable markets emerging?
Look East and South. Nations like India, China, Brazil, and South Africa are becoming global hubs for robotic surgery, driven by rising surgical volumes, cost-effective treatment models, and investor-friendly regulations. For instance, …